Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pioglitazone for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Risk for the Development of Type 2 Diabetes Mellitus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431895/all/images/google-play-badge.png. Accessed 02 May 2024.
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431895/all/images/google-play-badge.png. Accessed May 2, 2024.
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431895/all/images/google-play-badge.png
Pioglitazone for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Risk for the Development of Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431895/all/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
ID - 431895
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431895/all/images/google-play-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -